Congratulations to the following winners of the 2026 DOM Research Competition (list in alpha order):
Mark Chandy (Cardiology) will receive $100,000 over 2 years for their project entitled “GRACE (Genistein for the Reduction of Adverse Cardiovascular Events)”.
Dervla Connaughton (Nephrology) will receive $100,000 over 2 years for their project entitled “COST-CKD: Costing, Modelling and Valuing Genomic Testing for Chronic Kidney Disease in Ontario”.
Susan Huang (Nephrology) will receive $99,784 over 2 years for their project entitled “Personalized dialysate sodium for patients receiving maintenance hemodialysis (MySALT): a pragmatic randomized trial”.
Ameya Patwardhan (Geriatric Medicine) will receive $100,000 over 2 years for their project entitled “From Tap Test to Shunt: Developing a Pragmatic Multidomain Outcome Assessment Framework for Idiopathic Normal Pressure Hydrocephalus”.
Aze Wilson (Gastroenterology) will receive $100,000 over 2 years for their project entitled “Pharmacogenetics and Drug Response: An Integrated Clinical-Molecular Risk Score to Guide Biologic Therapy Decision-Making at Crohn's Disease Diagnosis (A Pilot Study)
Mark Chandy (Cardiology) will receive $100,000 over 2 years for their project entitled “GRACE (Genistein for the Reduction of Adverse Cardiovascular Events)”.
Dervla Connaughton (Nephrology) will receive $100,000 over 2 years for their project entitled “COST-CKD: Costing, Modelling and Valuing Genomic Testing for Chronic Kidney Disease in Ontario”.
Susan Huang (Nephrology) will receive $99,784 over 2 years for their project entitled “Personalized dialysate sodium for patients receiving maintenance hemodialysis (MySALT): a pragmatic randomized trial”.
Ameya Patwardhan (Geriatric Medicine) will receive $100,000 over 2 years for their project entitled “From Tap Test to Shunt: Developing a Pragmatic Multidomain Outcome Assessment Framework for Idiopathic Normal Pressure Hydrocephalus”.
Aze Wilson (Gastroenterology) will receive $100,000 over 2 years for their project entitled “Pharmacogenetics and Drug Response: An Integrated Clinical-Molecular Risk Score to Guide Biologic Therapy Decision-Making at Crohn's Disease Diagnosis (A Pilot Study)
